---
figid: PMC9637986__fphar-13-1005438-g004
pmcid: PMC9637986
image_filename: fphar-13-1005438-g004.jpg
figure_link: /pmc/articles/PMC9637986/figure/F4/
number: FIGURE 4
figure_title: ''
caption: 'The effect of Chaigui granule on mRNA expression of CYP19A1-E2-ERK1/ERK2
  pathway in the hippocampus. (A) The expression of CYP19A1 mRNA in the hippocampus.
  (B) The expression of AR mRNA in the hippocampus. (C) The expression of ERα mRNA
  in the hippocampus. (D) The expression of ERβ mRNA in the hippocampus. (E) The expression
  of ERK1 mRNA in the hippocampus. (F) The expression of ERK2 mRNA in the hippocampus.
  All data were expressed as mean ± SD. #p < 0.05, ##p < 0.01 compared with Control
  group. ✻p < 0.05, ✻✻p < 0.01 compared with Model group.'
article_title: Chaigui granule exerts anti-depressant effects by regulating the synthesis
  of Estradiol and the downstream of CYP19A1-E2-ERKs signaling pathway in CUMS-induced
  depressed rats.
citation: Jun-sheng Tian, et al. Front Pharmacol. 2022;13:1005438.
year: '2022'

doi: 10.3389/fphar.2022.1005438
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- chaigui granule
- depression
- CYP19A1-E2-ERKs signaling pathway
- chronic unpredictable mild stress
- xiaoyao san

---
